RxSight Inc (RXST)
51.26
+0.16
(+0.32%)
USD |
NASDAQ |
Nov 04, 16:00
51.26
0.00 (0.00%)
After-Hours: 20:00
RxSight Gross Profit Margin (Quarterly): 69.51% for June 30, 2024
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 69.51% |
| March 31, 2024 | 70.09% |
| December 31, 2023 | 61.77% |
| September 30, 2023 | 61.85% |
| June 30, 2023 | 57.74% |
| March 31, 2023 | 59.27% |
| December 31, 2022 | 46.13% |
| September 30, 2022 | 42.46% |
| June 30, 2022 | 42.15% |
| Date | Value |
|---|---|
| March 31, 2022 | 42.06% |
| December 31, 2021 | 34.05% |
| September 30, 2021 | 23.18% |
| June 30, 2021 | -16.58% |
| March 31, 2021 | 32.12% |
| December 31, 2020 | 28.08% |
| September 30, 2020 | 17.27% |
| June 30, 2020 | -17.52% |
| March 31, 2020 | 2.70% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
-17.52%
Minimum
Jun 2020
70.09%
Maximum
Mar 2024
36.46%
Average
42.10%
Median
Gross Profit Margin (Quarterly) Benchmarks
| Tandem Diabetes Care Inc | 50.83% |
| Twist Bioscience Corp | 43.30% |
| Perspective Therapeutics Inc | -- |
| Xtant Medical Holdings Inc | 62.06% |
| Catheter Precision Inc | 82.80% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -20.02% |
| Return on Assets | -17.54% |
| Return on Invested Capital | -19.61% |
| Profit Margin (Quarterly) | -17.42% |
| Operating Margin (Quarterly) | -23.89% |
| Return on Net Operating Assets | -69.25% |